
Congratulations to the chemical neuroscience research group at NCMM, which has just been renewed for a further four years.
Congratulations to the chemical neuroscience research group at NCMM, which has just been renewed for a further four years.
The Kuijjer group at NCMM have published a new article in the open access journal BMC Cancer.
NCMM group leader Irep Gözen recently published a perspectives article in ACS Nano, where she presents a new hypothesis for how cells were first able to divide on the early earth.
NCMM was pleased to host several representatives from the European Research Infrastructure for Translational Medicine (EATRIS) for the first national EATRIS Norway meeting earlier this week. The meeting was followed by a communications workshop for EATRIS national coordinators, and an open seminar by EATRIS Operations and Finance Director Anton Ussi.
Hosted by EMBL Barcelona, the 3rd annual EMBL Partnership Conference took place from 25-27 September 2019. A total of 25 NCMM members attended the meeting, including those who delivered talks and presented posters.
NCMM was represented by Irep Gözen and her research group at the annual Forskningstorget event at University Square in central Oslo.
NCMM was pleased to welcome Dr Leland Mayne from the University of Pennsylvania for a three-week visit during September. Dr Mayne is an expert in hydrogen-deuterium exchange coupled to mass spectrometry (HDX-MS), and his knowledge and guidance will help to establish excellent standards for HDX-MS at NCMM.
New work from the group led by Nikolina Sekulic at NCMM has been published in EMBO Reports.
EATRIS Norway is pleased to announce that the ‘EATRIS-Plus’ proposal has been funded by the European Commission under the INFRADEV-3 call, which concerns the development and long sustainability of new pan-European research infrastructures.
NCMM is recruiting for a new group leader in Precision Medicine. The role also includes a generous start-up package. Outstanding international candidates are encouraged to apply. Deadline: 15 September
Authors of a paper published in Nature Genetics include several NCMM Associate Investigators, heads of Norwegian EATRIS platforms, and scientists from the Finnish Nordic EMBL Partnership node, FIMM
A prestigious Horizon 2020-MSCA-ITN European Training Network grant has been awarded to a collaboration between a number of research groups and organisations which include the group of NCMM Assistant Director, Hartmut Luecke.
The 2019 NCMM scientific retreat took place at the Sundvolden Hotel on 12-13 June 2019.
The collaborative group, Translation Together, has published an article examining the skillset and qualities that make for a successful translational scientist.
NCMM's annual report for 2018 is now available.
Seed funding allocated to help encourage research collaborations across the wider NCMM network.
Five EATRIS members, including NCMM and the Finnish Nordic EMBL partnership node, FIMM, assist reproducibility study
NCMM Group Leader shared some insight into the mechanisms of the gene editing technique and its uses.
NCMM Associate Investigator, Professor Anne Simonesen, has been named as one of the winners of the King Olav V's Prize for Cancer Research 2019.
The four Nordic EMBL Partnership Directors are featured in an article by the EMBL, discussing the benefits of collaboration and what the EMBL means to them.
Professor Janna Saarela to join the Cellular and Molecular Biology group of the Academy’s Natural Sciences Division
Research led by Irep Gözen, head of the Bionanotechnology and Membrane Systems Group, is being presented at the Biophysical Society Annual Meeting in Baltimore, USA. The findings have also been highlighted in the Norwegian national newspaper, Aftenposten
NCMM’s group leaders, Board members, stakeholders and Associate and Young Associate Investigators gathered at the Thon Hotel Opera in central Oslo for the 4thannual NCMM Network Meeting on 26 and 27 February.
NCMM congratulates NCMM Associate Investigator and Board Member, Hilde Loge Nilsen, and colleague Evandro Fei Fang on their recent research which has found that the clearance of dysfunctional mitochondria slows down the progression of Alzheimer’s Disease
The group's latest publication features in JoVE (The Journal of Visualized Experiments)